FDA Takes Steps to Advance the Development of Novel Therapies for Stimulant Use Disorders - FDA.gov
fda.govSubmitted by fdagov3951 in health
The FDA published a new draft guidance related to clinical trials for development of therapies to treat stimulant use disorder